Connection
Michael Kahn to Precursor Cell Lymphoblastic Leukemia-Lymphoma
This is a "connection" page, showing publications Michael Kahn has written about Precursor Cell Lymphoblastic Leukemia-Lymphoma.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.169 |
|
|
|
-
Kim YM, Gang EJ, Kahn M. CBP/Catenin antagonists: Targeting LSCs' Achilles heel. Exp Hematol. 2017 08; 52:1-11.
Score: 0.102
-
Park E, Gang EJ, Hsieh YT, Schaefer P, Chae S, Klemm L, Huantes S, Loh M, Conway EM, Kang ES, Hoe Koo H, Hofmann WK, Heisterkamp N, Pelus L, Keerthivasan G, Crispino J, Kahn M, Müschen M, Kim YM. Targeting survivin overcomes drug resistance in acute lymphoblastic leukemia. Blood. 2011 Aug 25; 118(8):2191-9.
Score: 0.068